|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas显示文摘 | Rades D Schild SE | 2006 | 中国神经肿瘤杂志2006，4，1： | 11 |
| 2 | Steady-state conversion of methane to C4+ aliphatic products in high yields using an integrated recycle reactor system显示文摘 | Pak S Rades T Rosynek M P Lunsford J H | | 0，，： | 2 |
| 3 | Radiolabeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC)显示文摘 | Rades D Nadrowitz R Buchmann I Hunold P Noack F Schild SE Meller B. | 2010 | 中国神经肿瘤杂志2010，8，3： | 2 |
| 4 | Personalizing medicine for metastatic colorectal cancer:Current developments显示文摘Metastatic colorectal cancer(mCRC)is still one of the tumor types with the highest incidence and mortality.In 2012,colorectal cancer was the second most prevalence cancer among males(9%)and the third among females(8%).In this disease,early diagnosis is important to improve treatment outcomes.However,at the time of diagnosis,about one quarter of patients already have metastases,and overall survival of these patients at 5-years survival is very low.Because of these poor statistics,the development of new drugs against specific targets,including the pathway of angiogenesis,has witnessed a remarkable increase.So,targets therapies through epidermal growth factor and its receptor and also KRAS pathways modulation acquired a main role whether in association with standard chemotherapy and radiotherapy.With the current knowledge in the field of molecular biology,including genetic mutations and polymorphisms,we know better why patients respond so differently to the same treatments.So,in the future we can develop increasingly personalized treatments to the patient and not the disease.This review aims to summarize some molecular pathways and their relation to tumor growth,as well as novel targeted developing drugs and recently approved for mCRC. | rea Marin Marques Alice Turner Ramon rade de Mello | 2014 | World Journal of Gastroenterology2014，20，30： | 2 |
| 5 | Epoetin alia inproves survival after chemoradiation for stage III esophageal cancer:final results of a prospective observational study 显示文摘 | Rades D Tribius S Yekebas EF | 2006 | Int J Radiat Oncol Biol Phys2006，65，： | 1 |
| 6 | Enhanced dissolution rate and synchronized release of drugs in bi-nary systems through formulation:amorphous naproxen-cimetidine mixtures prepared by mechanical activation显示文摘 | Alleso M Chieng N Rehder S Rantanen J Rades T Aaltonen J | 2009 | J Contr Rel2009，136，： | 1 |
| 7 | Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy 显示文摘 | Saupe A Gordon KC Rades T | 2006 | Int J Pharm2006，314，1： | 1 |
| 8 | A boost in addition to whole-brain radiotherapy improves patient out- come after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients 显示文摘 | RADES D PLUEMER A VENINGA T | 2007 | Cancer2007，110，： | 1 |
| 9 | Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients 显示文摘 | Rades D Fehlauer F Bajrovic A | 2004 | Radiother Oncol2004，70，3： | 1 |
| 10 | LEOPARD-II:A randomized phase II study of radiochemotherapy RCT with 5FU and cisplatin plusminus cetuximab Cet in unresectable locally advanced esophageal cancer LAEC显示文摘 | Rades D Moehler MH Debus J | 2014 | J Clin Oncol2014，，： | 1 |
| 11 | Treatment for central neurocytoma:a meta-analysis based on the data of 358 patients显示文摘 | Rades D Fehlauer F Schild S | 2003 | Strahlenther Onkol2003，179，4： | 1 |
| 12 | Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions显示文摘 | Watasirichaikul S Davies N M Rades R | 2000 | Pharm Res2000，17，： | 1 |
| 13 | Reliability Equivalence显示文摘 | Rade L | 1993 | Microelectron Reliab1993，33，： | 1 |
| 14 | Characterization of gelatin based films modified with transgluta minase, glyoxal and for maldehyde显示文摘 | CARVALHO RAde GROSSO CRF | 2004 | Food Hydroeolloids2004，18，： | 1 |
| 15 | Fast sequencing of oligosaccharides:the reagent-array analysis method显示文摘 | EDGE C J RADE T W WORMALD M R | 1992 | Proc Nail Acad Sci1992，89，4： | 1 |
| 16 | Preparation of Biodegradable Insulin Nanocapsules from Biocompatible Microemulsions显示文摘 | WATNASIRICHAIKU S DAVIES N M RADES T | 2000 | Pharmaceutical Research2000，17，： | 1 |
| 17 | Reliability Survival Equivalence显示文摘 | Rade L | 1993 | Microelectron Reliab1993，33，： | 1 |
| 18 | Comparative study of liposomes, transfersomes, ethosomes and cubo- somes for transcutaneous immunisation: eharacterisation and in vitro skin penetration显示文摘 | Rattanapak T Young K Rades T | 2012 | J Pharm Pharmacol2012，64，11： | 1 |
| 19 | Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer显示文摘 | Reers S Pfannerstill AC Rades D | 2013 | Anticancer Res2013，33，6： | 1 |
| 20 | Defining thoptimal dose of radiation after incomplete resection of central neurocytomase 显示文摘 | RADES D SCHILD SE IKEZAKI K | 2003 | Radiat Oncol Biol Phys2003，55，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员